Calculating QALYs, comparing QALY and DALY calculations

Health Policy and Planning

Volumn 21, Issue 5, 2006, Pages 402-408

  Sassi, Franco ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cost effectiveness analysis; Disability adjusted life years; Outcome assessment; Quality adjusted life years

Indexed keywords

ARTICLE; BIPOLAR DEPRESSION; CALCULATION; CLINICAL ASSESSMENT TOOL; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISABILITY ADJUSTED LIFE YEAR; DISEASE DURATION; HEALTH CARE POLICY; HUMAN; MANAGEMENT; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TUBERCULOSIS;

DISABILITY EVALUATION; GREAT BRITAIN; HUMANS; QUALITY-ADJUSTED LIFE YEARS; STATISTICS;

EID: 33750094121     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czl018     Document Type: Article

References (31)

1. Anand S, Hanson K. 1997. Disability-adjusted life years: a critical review. Journal of Health Economics 16: 685-702.
2. Arnesen T, Nord E. 1999. The value of DALY life: problems with ethics and validity of disability adjusted life years. British Medical Journal 319: 1423-5.
3. Bleichrodt H, Johannesson M. 1996. The validity of QALYS: an experimental test of constant proportional trade-off and utility independence. Medical Decision Making 17: 21-32.
4. Broome J. 1993. QALYs. Journal of Public Economics 50: 149-63.
5. Bush JW, Fanshel S, Chen MM. 1972. Analysis of a tuberculin testing program using a health status index. Journal of Socio-Economic Planning Sciences 6: 49-69.
6. Bush JW, Chen MM, Patrick DL. 1973. Health status index in cost-effectiveness analysis of PKU programme. In: Berg RL (ed). Health status indexes. Chicago, IL: Hospital Research and Educational Trust.
7. Dion M, Tousignant P, Bourbeau J et al. 2002. Measurement of Health Preferences among Patients with Tuberculous Infection and Disease. Medical Decision Making 22: S102-S114.
8. Dolan P. 1997. Modeling valuations for EuroQol health states. Medical Care 35: 1095-108.
9. Drummond MF, Sculpher MJ, Torrance GW et al. 2005. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
10. Fanshel S, Bush JW. 1970. A health-status index and its application to health-services outcomes. Operations Research 18: 1021-66.
11. Fox-Rushby J, Hanson K. 2001. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy and Planning 16: 326-31.
12. Gerard K. 1992. Cost-utility in practice: a policy maker's guide to the state of the art. Health Policy 21: 249-79.
13. Gold MR, Siegel JE, Russell LB et al. (eds). 1996. Cost-effectiveness in health and medicine. New York: Oxford University Press.
14. Klarman HE, Francis JOS, Rosenthal GD. 1968. Cost-effectiveness analysis applied to the treatment of chronic renal disease. Medical Care 6: 48-54.
15. Loomes G, McKenzie L. 1989. The use of QALYs in health care decision-making. Social Science and Medicine 28: 229-308.
16. McPake B, Kumaranayake L, Normand C. 2002. Health economics. An international perspective. London: Routledge.
17. Mehrez A, Gafni A. 1989. Quality adjusted life years, utility theory, and healthy years equivalents. Medical Decision Making 9: 142-9.
18. Murray C. 1994. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 72: 429-45.
19. Murray CJ, Acharya AK. 1997. Understanding DALYs (disability-adjusted life years). Journal of Health Economics 16: 703-30.
20. Murray CJL, Lopez AD. 1996. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press.
21. Myamoto JM, Eraker SA. 1985. Parameter estim for a QALY utility model. Medical Decision Making 5: 191-213.
22. Pliskin JS, Shepard DS, Weinstein MC. 1980. Utility functions for life years and health status. Operations Research 28: 206-24.
23. Sassi F, Archard L, Le Grand J. 2001. Equity and the economic evaluation of healthcare. Health Technology Assessment 5: 1-138.
24. Torrance GW. 1970. A generalized cost-effectiveness model for the evaluation of health programs. Research report 101. Hamilton, Ontario: McMaster University, Faculty of Business.
25. Torrance GW. 1976. Health status index models: a unified mathematical view. Management Science 22: 990-1001.
26. Torrance GW. 1986. Measurement of health state utilities for economic appraisal. Journal of Health Economics 5: 1-30.
27. Torrance GW, Thomas WH, Sackett DL. 1972. A utility maximization model for the evaluation of health care programs. Health Services Research 7: 118-33.
28. Torrance GW, Feeny DH, Furlong WJ et al. 1996. Multiattribute Utility Function for a Comprehensive Health Status Classification System: Health Utilities Index Mark 2. Medical Care 34: 702-22.
29. Tsevat J, Keck PE, Hornung RW et al. 2000. Health values of patients with bipolar disorder. Quality of Life Research 9: 579-86.
30. Williams A. 1999. Calculating the global burden of disease: time for a strategic re-appraisal. Health Economics 8: 1-8.
31. Zeckhauser R, Shepard DS. 1976. Where now for saving lives? Law and Contemporary Problems 40: 5-45.